We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants
SGYPW

Delisted

SGYPW was delisted on the 6th of December, 2016.

Back to rankings

3 hedge funds and large institutions have $289K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,308% more capital invested

Capital invested by funds: $12K → $289K (+$277K)

108% more call options, than puts

Call options by funds: $4.42M | Put options by funds: $2.13M

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more funds holding

Funds holding: 2 → 3 (+1)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
$4.42M
Puts
$2.13M
Net Calls
+$2.29M
Net Calls Change
+$2.55M

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$210K
2
Twin Tree Management
Twin Tree Management
Texas
+$5.67K
3
UBS Group
UBS Group
Switzerland
+$188

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$268K +$210K +348,743 New
Twin Tree Management
2
Twin Tree Management
Texas
$21K +$5.67K +9,400 +47%
UBS Group
3
UBS Group
Switzerland
– +$188 +312 New

SGYPW Hedge Fund Activity: Q3 2016 in Review

3 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q3 2016, worth a combined $289K — up 2,308% from $12K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new SGYPW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $210K.

  • 3 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q3 2016, up from 2 in Q2 2016.
  • Funds reported $289K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q3 2016, up 2,308% quarter-over-quarter.
  • 2 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q3 2016 and 1 closed out, a net change of +1 holder.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q3 2016 was Sabby Management, an estimated $210K added.

Based on aggregated 13F filings for Q3 2016.